Cargando…
C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009667/ https://www.ncbi.nlm.nih.gov/pubmed/36582013 http://dx.doi.org/10.1002/cac2.12391 |
| _version_ | 1784906034262835200 |
|---|---|
| author | Song, Haiping Arredondo Carrera, Hector Manuel Sprules, Alexandria Ji, Ying Zhang, Tongsong He, Jiepei Lawrence, Eleanor Gartland, Alison Luo, Jian Wang, Ning |
| author_facet | Song, Haiping Arredondo Carrera, Hector Manuel Sprules, Alexandria Ji, Ying Zhang, Tongsong He, Jiepei Lawrence, Eleanor Gartland, Alison Luo, Jian Wang, Ning |
| author_sort | Song, Haiping |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10009667 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100096672023-03-14 C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data Song, Haiping Arredondo Carrera, Hector Manuel Sprules, Alexandria Ji, Ying Zhang, Tongsong He, Jiepei Lawrence, Eleanor Gartland, Alison Luo, Jian Wang, Ning Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2022-12-29 /pmc/articles/PMC10009667/ /pubmed/36582013 http://dx.doi.org/10.1002/cac2.12391 Text en © 2022 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Song, Haiping Arredondo Carrera, Hector Manuel Sprules, Alexandria Ji, Ying Zhang, Tongsong He, Jiepei Lawrence, Eleanor Gartland, Alison Luo, Jian Wang, Ning C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data |
| title | C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data |
| title_full | C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data |
| title_fullStr | C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data |
| title_full_unstemmed | C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data |
| title_short | C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data |
| title_sort | c‐terminal variants of the p2x7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009667/ https://www.ncbi.nlm.nih.gov/pubmed/36582013 http://dx.doi.org/10.1002/cac2.12391 |
| work_keys_str_mv | AT songhaiping cterminalvariantsofthep2x7receptorareassociatedwithprostatecancerprogressionandbonemetastasisevidencefromclinicalandpreclinicaldata AT arredondocarrerahectormanuel cterminalvariantsofthep2x7receptorareassociatedwithprostatecancerprogressionandbonemetastasisevidencefromclinicalandpreclinicaldata AT sprulesalexandria cterminalvariantsofthep2x7receptorareassociatedwithprostatecancerprogressionandbonemetastasisevidencefromclinicalandpreclinicaldata AT jiying cterminalvariantsofthep2x7receptorareassociatedwithprostatecancerprogressionandbonemetastasisevidencefromclinicalandpreclinicaldata AT zhangtongsong cterminalvariantsofthep2x7receptorareassociatedwithprostatecancerprogressionandbonemetastasisevidencefromclinicalandpreclinicaldata AT hejiepei cterminalvariantsofthep2x7receptorareassociatedwithprostatecancerprogressionandbonemetastasisevidencefromclinicalandpreclinicaldata AT lawrenceeleanor cterminalvariantsofthep2x7receptorareassociatedwithprostatecancerprogressionandbonemetastasisevidencefromclinicalandpreclinicaldata AT gartlandalison cterminalvariantsofthep2x7receptorareassociatedwithprostatecancerprogressionandbonemetastasisevidencefromclinicalandpreclinicaldata AT luojian cterminalvariantsofthep2x7receptorareassociatedwithprostatecancerprogressionandbonemetastasisevidencefromclinicalandpreclinicaldata AT wangning cterminalvariantsofthep2x7receptorareassociatedwithprostatecancerprogressionandbonemetastasisevidencefromclinicalandpreclinicaldata |